基于高分子材料的降眼压药物递送系统

黄畅, 赵玉瑾, 徐建江, 孙兴怀, 孙建国 - 功能高分子学报, 2021 - gngfzxb.ecust.edu.cn
Sustained release of brimonidine from a new composite drug delivery system for
treatment of glaucoma [J]. ACS Applied Materials & Interfaces,2017,9(9):7990-7999. [37] …

保护视神经的结构和功能使用新药物和设备保存视力

NA Sharif - 中国神经再生研究(英文版), 2018 - sjzsyj.com.cn
… forms of glaucoma including primary open-angle glaucoma (… Whilst certain long-term drug
delivery approaches and … synthesized, formulated and delivered intravitreally to slow down the …

青光眼治疗的新观点: 丰富的环境

MFG Fleitas, D Dorfman, RE Rosenstein - 中国神经再生研究(英文版), 2022 - sjzsyj.com.cn
glaucoma through weekly injections of chondroitin sulfate (CS) in the eye anterior chamber
of Wistar rats. Weekly intracameral injections … transport (intravitreal injection of cholera toxin β-…

合成高分子基温敏水凝胶在眼病治疗中的研究进展

刘敏华, 南开辉, 陈杨军 - 高分子学报, 2021 - gfzxb.org
treatment of … as ideal drug delivery systems (DDSs) with sustained-release feature,
receiving extensive attention in the field of ocular drug delivery. At room temperature, thermogels …

[PDF][PDF] 眼部药物智能控释系统研究进展

吴彩清, 余敏斌, 杨扬帆 - 新医学, 2020 - xinyixue.cn
drug release system for ocular drugs has been conducted for a short period of time. The
controlled release system based on the in-situ gel drug delivery … research of ocular drug delivery. …

大麻素和内源性大麻素作为治疗神经系统疾病的药物: 临床前模型和临床研究

RS Duncan, SM Riordan, MC Gernon… - 中国神经再生研究(英文 …, 2024 - sjzsyj.com.cn
Intravitreal administration of the CB1 inverse agonist, AM251, or the CB2 inverse agonist, …
via depot injection into young DBA/2 mice, a commonly utilized mouse model of glaucoma, to …

视网膜色素变性治疗循证指南(2021 年)

Chinese Eye Genetics Consortium - 眼科, 2021 - j-bio.net
… of previous treatments is ambiguous. The emerging gene therapy and cell therapy for RP have
… tients with retinitis pigmentosa submitted to intravitreal use of bone marrow1derived stem …

无长突细胞选择性敲除锌转运蛋白3 可促进视网膜神经节细胞存活和视神经再生

Z Liu, J Xue, C Liu, J Tang, S Wu, J Lin, J Han… - 中国神经再生研究 …, 2023 - sjzsyj.com.cn
… In some experiments, animals were injected intravitreally with 3 µL of vehicle (phosphate-…
Multiple models, including chronic experimental glaucoma models, are required to confirm …